Recent evidence suggests that circulating resistin concentrations do not reflect the degree of obesity in humans [15,16,17], but it is related to some inflammatory diseases, such as chronic kidney disease, rheumatoid arthritis, coronary atherosclerosis, T2 diabetes mellitus, and sepsis [18,19]. Here, RETN is linked to obesity disorder.